Sensitive ASX Announcement

Imugene Receives Third PD1-VAXX Ethics Trial Approval

Published: 21/08/20, 09:00am (AEST)2 pages
Imugene Limited
IMU:ASXHealthcare

Recent IMU Announcements

Price Sensitive only